Long QT Syndrome medical and device therapy: Difference between revisions

	Xyz Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Long QT Syndrome medical and device therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Long QT Syndrome medical and device therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Long QT Syndrome medical and device therapy
CDC on Long QT Syndrome medical and device therapy
Long QT Syndrome medical and device therapy in the news
Blogs on Long QT Syndrome medical and device therapy
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Long QT Syndrome medical and device therapy

Revision as of 18:19, 10 March 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include:

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Long QT Syndrome}}
+{{Xyz}}
 {{CMG}}; {{AE}}
 ==Overview==
-There are no established measures for the primary prevention of [disease name].
+There are no established measures for the secondary prevention of [disease name].
 OR
-There are no available vaccines against [disease name].
+Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
-OR
+==Secondary Prevention==
+There are no established measures for the secondary prevention of [disease name].
-Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
-OR
-[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
-==Primary Prevention==
-There are no established measures for the primary prevention of [disease name].
-OR
-There are no available vaccines against [disease name].
-OR
-Effective measures for the primary prevention of [disease name] include:
-*[Measure1]
-*[Measure2]
-*[Measure3]
 OR
-[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
+Effective measures for the secondary prevention of [disease name] include:
 *[Strategy 1]
 *[Strategy 2]
@@ Line 44: / Line 25: @@
 {{WH}}
 {{WS}}
+[[Category: (name of the system)]]